Treatment
GnRH agonist clinical trials
We’re tracking 17 recruiting studies that include GnRH agonist, each written for real people, not researchers, below.
Recruiting studies
- NCT06150703RecruitingPhase 3
Luteal phase support with GnRH agonist after egg retrieval trigger
This trial tests whether giving a medication called a GnRH agonist during the luteal phase (the time after egg retrieval) can help with IVF success. It is for people who are using a specific medication protocol (recombinant FSH with an antagonist) and have certain hormone levels.
BondyAges 18–39 - NCT04356664RecruitingPhase 2/Phase 3
GnRH shot before frozen embryo transfer for endometriosis
This trial studies whether giving a GnRH “downshifting” shot before transferring a frozen embryo can improve pregnancy outcomes for people with endometriosis or adenomyosis. It may help by changing hormone activity before the transfer.
SuresnesAges 18–36 - NCT07128394Recruiting
Extra LH hormone for better embryos in IVF with low LH
This trial tests whether giving extra luteinizing hormone (LH) can improve embryo quality in women with very low LH levels during IVF. It may help you if you have low LH and are using a specific type of fertility medication.
Nanjing, JiangsuAges 20–37 - NCT07771283Enrolling by invitation
Comparing ovarian stimulation methods for IVF
This study compares two methods of stimulating the ovaries before IVF: one using a standard hormone (hCG) and another using a different protocol. The goal is to see if the new method works as well as the standard one, while possibly being more cost-effective.
KampalaAges 18–40 - NCT07620067Recruiting
GnRH Hormone for IVF Embryo Support
This study tests whether a hormone called GnRH can improve success rates during IVF (in vitro fertilization) by supporting the embryo after transfer. If you're having IVF for the first to third time and your doctor is considering different support methods, this trial may explore options for you.
JerusalemAges 18–45 - NCT07696351RecruitingPhase 4
Ultrasound-guided endometrial preparation for endometriosis
This trial tests whether a 2-3 month hormone treatment before a frozen embryo transfer improves pregnancy success in women with deep endometriosis. It may help your body prepare better for the embryo.
Nanjing, JiangsuAges 18–39 - NCT04064840RecruitingPhase 3
Hormone treatment to improve IVF trigger and FET support
This study tests whether a specific hormone plan can improve outcomes in two parts of fertility treatment: IVF timing (the “trigger”) and hormone support during frozen embryo transfer (FET). It may help some people have better chances for successful embryo implantation and pregnancy.
Hong Kong, Hong KongAges 18–42 - NCT06995261Recruiting
Follitropin delta in a long hormone-suppression IVF cycle
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
Düsseldorf, North Rhine-WestphaliaAges 18–44 - NCT03463252RecruitingPhase 2/Phase 3
Hormone IUD to preserve fertility in early uterine cancer
This study looks at whether a hormone-releasing IUD (LNG-IUS) can treat early-stage endometrial cancer or very early abnormal cell growth while helping you keep the option for future pregnancy. It aims to see how well the treatment works and how it affects fertility-related outcomes.
Chengdu, SichuanAges Up to 40 years - NCT05478083RecruitingPhase 2
Leuprolide treatment for severe polycystic liver growth
This Phase 2 study tests whether a monthly hormone medicine (leuprolide, a GnRH agonist given as an injection) can slow down ongoing, fast-growing polycystic livers. It is aimed at pre-menopausal women with very large livers that are still getting bigger on past and current scans.
Nijmegen, GelderlandAges 18–45 - NCT05765500RecruitingPhase 2
Relugolix vs leuprolide to improve prostate cancer quality of life
This Phase 2 study compares two medicines that lower testosterone—relugolix tablets versus leuprolide injections—to see which better improves quality of life. It’s for people with prostate cancer who are starting hormone treatment and have not used similar testosterone-lowering drugs before.
Boston, MassachusettsAges 18 years+ - NCT06225284RecruitingPhase 2
Chemotherapy with or without hormone drug for premenopausal TNBC
This trial tests whether adding a hormone-blocking drug (GnRH agonist) to standard chemotherapy before surgery helps premenopausal women with triple-negative breast cancer. It aims to improve treatment outcomes by targeting hormones that may fuel tumor growth.
TaipeiAges 18 years+ - NCT06525155RecruitingPhase 3
GnRH agonist for endometriosis cysts
This trial tests a drug called GnRH agonist to see if it helps people with endometriosis cysts. It might offer a new treatment option for those with this condition.
JakartaAges 18–40 - NCT07319429RecruitingPhase 2/Phase 3
Fertility-sparing treatment for endometrial cancer based on molecular type
This trial tests a tailored approach to preserve fertility in women with early-stage endometrial cancer, using medications like hormones and immunotherapy based on the tumor's molecular subtype. It aims to avoid hysterectomy and keep the uterus intact.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT06239376Recruiting
Hormone pretreatment before frozen embryo transfer for adenomyosis
This study tests whether using a hormone medication (GnRH agonist) before a frozen embryo transfer helps women with adenomyosis. If you have adenomyosis and are planning a frozen embryo transfer, this trial will help compare results with or without the pre-treatment.
Ho Chi Minh City, Ho Chi Minh CityAges 18–42 - NCT06691815Enrolling by invitation
Triptorelin test for diagnosing delayed puberty
This study uses a hormone called triptorelin to help doctors find the cause of delayed or stalled puberty in teenagers and young adults. The goal is to see if this medicine can clearly tell whether the problem is in the brain or elsewhere in the body.
Buenos AiresAges 13 years+ - NCT07171970Recruiting
IVM vs IVF for women with PCOS
This trial compares two fertility treatments for women with PCOS: in vitro maturation (IVM) with fresh embryo transfer versus standard IVF with frozen embryo transfer. It aims to find which approach leads to better outcomes.
Ho Chi Minh CityAges 18–42
What GnRH agonist is being studied for
Conditions with recruiting GnRH agonist studies.
Common questions
- Are there clinical trials studying GnRH agonist?
- Yes. Clin2 currently lists 17 recruiting studies that include GnRH agonist, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a GnRH agonist trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is GnRH agonist an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether GnRH agonist or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.